News & Updates

A 74-year-old nonsmoker and non­drinker presented to a private urologist in January 2025 with gross haematu­ria. Aside from benign prostatic hyper­plasia, he was well and physically fit. On 14 January 2025, a CT scan re­vealed a large mass measuring 5.8 cm with full-thickness infiltration into the bladder wall, consistent with clinical T3 disease. A metastatic lymph node (LN) of approximately 1.0 cm was not­ed in the left internal iliac region, with no distant metastases. 

Prof Axel Merseburger, Chairman of the Department of Urology at the University Hospital of Schleswig-Holstein in Lübeck, Germany, shares four metastatic hormone-sensitive prostate cancer (mHSPC) patient cases, discusses available treatment options and examines how individual characteristics determine optimal management.